Neuropharmacological Effects in Animal Models and HPLC-Phytochemical Profiling of Byrsonima crassifolia (L.) Kunth Bark Extracts

Molecules. 2023 Jan 12;28(2):764. doi: 10.3390/molecules28020764.

Abstract

B. crassifolia is a species that grows in various areas of Latin America. It was known to be useful for the treatment of different human ailments. The present work evaluated the neuropharmacological and analgesic effects of hydroalcoholic and dichloromethane extracts of B. crassifolia. The effect on the central nervous system (CNS) of both extracts obtained from bark, administered by the intraperitoneal route in mice, was evaluated by different tests: spontaneous motor activity, hole-board, motor coordination, pentobarbital induced hypnosis, and rectal temperature. Analgesic activity was evaluated using a hot plate test. Phytochemical analysis was performed by high-performance liquid chromatography (HPLC) using reversed-phase and gradient of elution. The hydroalcoholic extract (dose 0.5 g dry plant/kg weigh) administration caused an important reduction of the head-dipping response in the hole board test. A decrease in spontaneous motor activity test and a disturbance of motor coordination in the rotarod test was observed. The hydroalcoholic extract produced a significant prolongation of pentobarbital induced sleeping time. This extract prevented hot plate test induced nociception. The phytochemical analysis revealed the presence of catechin, epicatechin, and procyanidin B12. Therefore, this study revealed that the hydroalcoholic extract of B. crassifolia possesses analgesic and sedative CNS activity.

Keywords: B. Crassifolia; CNS activity; analgesic activity; hole-board test; motor coordination test; phytochemical analysis.

MeSH terms

  • Analgesics / pharmacology
  • Animals
  • Behavior, Animal
  • Chromatography, High Pressure Liquid
  • Humans
  • Mice
  • Models, Animal
  • Motor Activity
  • Pentobarbital* / pharmacology
  • Plant Bark
  • Plant Extracts* / chemistry

Substances

  • Plant Extracts
  • Pentobarbital
  • Analgesics

Grants and funding

This research received no external funding.